NICE director issues warning over Wegovy weight loss drug
A ground-breaking weight loss drug will not be made available to ‘everyone’, a senior healthcare professional has warned.
Semaglutide – better known as Wegovy - aids weight loss in adults and teens by making users feel fuller for longer. Manufactured by Novo Nordisk, the potentially game-changing drug has proved so popular in the United States that they are experiencing widespread shortages.
Now, it has been deemed safe and effective by the National Institute for Health and Excellence (NICE) and was approved for use by NHS England at the beginning of March.
Find out how technology is transforming the pharma supply chain by registering your interest in the latest LogiPharma report for free.
However, Helen Knight, director of medicines evaluation at NICE, said: “For some people losing weight is a real challenge, which is why a medicine like semaglutide is a welcome option.
"It won't be available to everyone. Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years.”
According to NICE, Wegovy is designed to be used alongside a low-calorie diet and increased exercise. And Dr Stephen Lawrence of the University of Warwick stressed it is not a miracle cure. He said: “It is important to note that this medication is not a quick fix or a replacement for following a healthy lifestyle, which includes regular physical activity and healthy eating.”
Who is eligible for Wegovy?
Treatment will be recommended for adults who have at least one weight-related condition and a body mass index (BMI) of 35 or more. Wegovy may also be available for those with a BMI that puts them near the top of the obese range. According to NICE, weight-related conditions include type 2 diabetes, high blood pressure, heart disease and obstructive sleep apnoea.
How does Wegovy work?
The drug mimics the action of a gut hormone called GLP-1, which is released after eating and makes people feel fuller for longer. As a result, Wegovy should reduce a person’s calorie intake and aid with weight loss.
How is Wegovy taken?
Patients on the NHS will inject themselves once a week using pre-filled pens or have it administered by a professional.
Are there any side effects?
Like any drug, Wegovy comes with some side effects and risks. Nausea has been found to be common when people first start using the drug. Other side effects include stomach pain, vomiting, diarrhea and constipation.